AU5733696A - Compositions comprising bismuth and one or more antimicrobia ls, for the treatment and prevention of gastrointestinal dis orders - Google Patents

Compositions comprising bismuth and one or more antimicrobia ls, for the treatment and prevention of gastrointestinal dis orders

Info

Publication number
AU5733696A
AU5733696A AU57336/96A AU5733696A AU5733696A AU 5733696 A AU5733696 A AU 5733696A AU 57336/96 A AU57336/96 A AU 57336/96A AU 5733696 A AU5733696 A AU 5733696A AU 5733696 A AU5733696 A AU 5733696A
Authority
AU
Australia
Prior art keywords
antimicrobia
bismuth
prevention
compositions
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU57336/96A
Other languages
English (en)
Inventor
Jamesina Anne Fitzgerald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of AU5733696A publication Critical patent/AU5733696A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU57336/96A 1995-05-09 1996-05-08 Compositions comprising bismuth and one or more antimicrobia ls, for the treatment and prevention of gastrointestinal dis orders Abandoned AU5733696A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43747595A 1995-05-09 1995-05-09
US437475 1995-05-09
PCT/US1996/006489 WO1996035436A1 (fr) 1995-05-09 1996-05-08 Compositions comprenant du bismuth et un ou plusieurs antimicrobiens, pour la prevention et le traitement de troubles gastro-intestinaux

Publications (1)

Publication Number Publication Date
AU5733696A true AU5733696A (en) 1996-11-29

Family

ID=23736610

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57336/96A Abandoned AU5733696A (en) 1995-05-09 1996-05-08 Compositions comprising bismuth and one or more antimicrobia ls, for the treatment and prevention of gastrointestinal dis orders

Country Status (6)

Country Link
EP (1) EP0830135A1 (fr)
JP (1) JPH11504940A (fr)
AU (1) AU5733696A (fr)
CA (1) CA2219758A1 (fr)
PE (1) PE48297A1 (fr)
WO (1) WO1996035436A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE288257T1 (de) 1999-04-06 2005-02-15 Ethypharm Sa Trinkbare pharmazeutische suspension von ibuprofen
FR2791888B1 (fr) * 1999-04-06 2004-10-08 Ethypharm Lab Prod Ethiques Suspension pharmaceutique buvable
CA2959414C (fr) 2014-09-05 2023-03-14 Symbiomix Therapeutics, Llc Secnidazole utilise dans le traitement d'une vaginose bacterienne

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62502967A (ja) * 1985-04-18 1987-11-26 ザ・プロクター・アンド・ギャンブル・カンパニー 非潰瘍消化不良症の治療
ATE81010T1 (de) * 1985-06-13 1992-10-15 Barry James Marshall Zusammensetzungen zur behandlung von magendarmst¯rungen.
DE3887353T2 (de) * 1987-10-12 1994-05-05 Exomed Australia Pty Ltd Behandlungsverfahren für magen-darm-krankheiten.
ATE184198T1 (de) * 1993-05-11 1999-09-15 Spirig Ag Festes bismut- und amoxycillinhaltiges arzneipräparat und seine verwendung

Also Published As

Publication number Publication date
WO1996035436A1 (fr) 1996-11-14
PE48297A1 (es) 1998-02-04
CA2219758A1 (fr) 1996-11-14
EP0830135A1 (fr) 1998-03-25
JPH11504940A (ja) 1999-05-11

Similar Documents

Publication Publication Date Title
ZA967034B (en) Pharmaceutical compositions.
ZA965190B (en) Pharmaceutical composition.
HU0500549D0 (en) Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof
ZA9610249B (en) Treatment of vegetables.
AU4966497A (en) Novel acylamino-substituted acylanilide derivatives or pharmaceutical composition comprising the same
HUP9904046A3 (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing the same
ZA9711508B (en) Rapidly disintegrable pharmaceutical composition.
ZA964711B (en) Novel compounds, the preparation and use thereof.
AU674358B2 (en) Novel 1,2-benzoisoxazole derivative or its salt and brain -protecting agent comprising the same
AU7125194A (en) Iodinated oligomeric compounds and diagnostic compositions containing the same
AU9778398A (en) Cellulose treatment and the resulting product
EP0614944A3 (fr) Composition intumescente du type deux-composantes.
AU5563298A (en) Uses of anti-glucocorticoid compounds for the treatment of psychoses or addictive behaviours
ZA964872B (en) Sunscreen compositions.
ZA968081B (en) Pharmaceutical composition.
AU7978794A (en) 3,17-dihydroxy-3,7,16 and/or 17-methyl-androst-5-ene compounds, derivatives thereof, and their use
ZA97252B (en) Compositions for the prevention and treatment of osteoporosis.
AU5798996A (en) Adnaz, compositions and processes
AU6872896A (en) 4,4-difluoro-3-butenylester derivatives or 4,4-difluoro-3-halogen-3-butenylester derivatives and the use thereof as pesticides
AU1630895A (en) Treatment of H. pylori infections
AU5733696A (en) Compositions comprising bismuth and one or more antimicrobia ls, for the treatment and prevention of gastrointestinal dis orders
AU6242494A (en) Slip resistant compositions and uses
ZA972708B (en) Pharmaceutical compositions and methods for the manufacture thereof.
AU2593597A (en) Compositions for the diagnosis and treatment of chediak-higashi syndrome
AU4107797A (en) Compounds for the treatment and prevention of diabetes